The effect of total knee arthroplasty (replacement) with the flexion first balancer or measured resection technique

ISRCTN ISRCTN85351296
DOI https://doi.org/10.1186/ISRCTN85351296
Secondary identifying numbers W18.007
Submission date
07/04/2021
Registration date
23/04/2021
Last edited
13/01/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Knee replacement surgery (arthroplasty) is a common operation that involves replacing a damaged, worn or diseased knee with an artificial joint. Adults of any age can be considered for a knee replacement, although most are carried out on people between the ages of 60 and 80.

With the use of a new technique, Flexion First Balancer (FFB), we are able to restore the joint line to its predisease level. We expect better functional outcome for these patients when we compare them to a matched patient group who were operated using the conventional technique, i.e. Measured resection (MR).

The difference between the two techniques is that in MR technique, a standardized amount of bone is resected to accommodate the knee prosthesis. First in extension these bone cuts are made and then in flexion. Resulting in an equal flexion and extension gap and therefore creating a stable knee prosthesis. Since the native medial and lateral side of the knee are not the same this might result in standard error with slight elevation of the joint line as a consequence.
In the Flexion First Balancer technique the bone cuts are first made in flexion and are dictated by the medial collateral ligament tension and therefore restores the medial knee anatomy. Later this flexion gap is copied to the extension gap and these extension cuts are dictated by the natural ligament tension of the knee. Therefore a more natural placement of the knee is possible which might benefit the patient.

Who can participate?
Patients who underwent TKA surgery via the FFB technique for Kellgren-Lawrence grade 3-4 osteoarthritis between September 2015 and November 2016, and patients who were operated on using the standard MR technique between September 2014 and July 2015

What does the study involve?
Two additional X-rays will be made to assess midflexion instability. Furthermore, three functional tests (6 minute walk test, stair climb test, static Quadriceps power test) will be conducted to examine functional outcome.

What are the possible benefits and risks of participating?
None

Where is the study run from?
Amphia Hospital in Breda (the Netherlands)

When is the study starting and how long is it expected to run for?
August 2018 to June 2019

Who is funding the study?
Amphia Hospital Wetenschapsfonds (Science-funding) (the Netherlands)

Who is the main contact?
W. van Lieshout, wvanlieshout@gmail.com

Contact information

Mr Willem van Lieshout
Public

Michiel van Miereveldlaan 6
Amstelveen
1181TM
Netherlands

ORCiD logoORCID ID 0000-0002-2220-6179
Phone +31(0)638304878
Email wvanlieshout@gmail.com

Study information

Study designCross-sectional cohort study single centre
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet ISRCTN85351296_PIS_v3_09Aug2018_in_Dutch.pdf
Scientific titleMidflexion Instability and Functional Outcome after total knee arthroplasty: flexion first balancer versus measured resection technique. The MIFO study
Study acronymMIFO
Study hypothesisSince the FFB technique restores the joint line to its pre-disease height this would result in less coronal mid-flexion laxity. Which, in turn could result in better functional outcome compared to the standard MR technique due to increased stability in the knee.
Ethics approval(s)Approved 05/09/2018, MEC-U (Koekoekslaan 1, Nieuwegein, 3430 EM, Netherlands; +31(0)306093580; info@mec-u.nl), ref: NL65535.100.18
ConditionTotal knee replacement for osteoarthritis
InterventionThis cross-sectional study has compared a group of patients operated with the Flexion First Balancer technique to a matched group who were operated using the conventional technique (Measured Resection).
Two additional X-rays were made with either varus or valgus stress in 30 degrees of flexion to assess midflexion instability.
Futhermore, three functional tests (6 minute walk test, stair climb test, static Quadriceps power test) were conducted to examine the functional outcome.

The mean time from TKA was: Follow up, mean (sd) 3.9 yrs (0.2) 2.6 yrs (0.4)
The investigation duration was 1 hour per person.
Intervention typeProcedure/Surgery
Primary outcome measureMid flexion laxity measured in millimetres on the medial or lateral side with either valgus or varus stress in 30 degrees of knee flexion measured at mean 3.9 years for the Measured resection group and a mean 2.6 years for the Flexion First Balancer group
Secondary outcome measuresFunctional outcomes measured at mean 3.9 years for the Measured resection group and a mean 2.6 years for the Flexion First Balancer group:
1. 6 minute walk test
2. Stair climb test
3. Static Quadriceps power test
Overall study start date01/08/2018
Overall study end date01/06/2019

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants60
Total final enrolment55
Participant inclusion criteria1. Patients who underwent TKA surgery via the FFB technique for Kellgren-Lawrence grade 3-4 osteoarthritis between September 2015 and November 2016
2. A historical matched cohort of patients who were operated on using the standard MR technique between September 2014 and July 2015 was used
Participant exclusion criteria1. Ill health
2. Degenerative diseases (e.g. rheumatoid arthritis) or development of severe osteoarthritis influencing functional test outcomes
3. Complications requiring consecutive surgery
4. Hip replacement or contralateral TKA within the past year.
Recruitment start date01/09/2018
Recruitment end date01/04/2019

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Amphia Hospital
Molengracht 21
Breda
4818 CK
Netherlands

Sponsor information

Amphia Ziekenhuis
Research council

Amphia Wetenschapscommisie
Molengracht 21
Breda
4818 CK
Netherlands

Phone +31 (0)765954251
Email wetenschap@amphia.nl
Website https://www.amphia.nl/opleiding-en-wetenschap/wetenschap/indieningsproces-wetenschappelijk-onderzoek
ROR logo "ROR" https://ror.org/01g21pa45

Funders

Funder type

Hospital/treatment centre

Amphia Ziekenhuis

No information available

Results and Publications

Intention to publish date01/05/2021
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
Publication and dissemination planPlanned publication in high -impact peer-reviewed journal.
IPD sharing planAll data generated or analysed during this study will be included in the subsequent results publication

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version v3 09/08/2018 04/05/2021 No Yes
Results article 09/12/2021 13/01/2022 Yes No

Additional files

ISRCTN85351296_PIS_v3_09Aug2018_in_Dutch.pdf
uploaded 04/05/2021

Editorial Notes

13/01/2022: Publication reference added.
04/05/2021: The participant information sheet was uploaded as an additional file.
22/04/2021: Trial's existence confirmed by MEC-U.